GZMB and leishmaniasis: Parasite-specific granzyme B production by human peripheral blood mononuclear cells (PBMCs) was found to be a good correlate of protection against Leishmania infection and could be a biomarker of vaccine-induced protection against human leishmaniasis (2, 47).